This is a Validated Antibody Database (VAD) review about human KDM2B, based on 4 published articles (read how Labome selects the articles), using KDM2B antibody in all methods. It is aimed to help Labome visitors find the most suited KDM2B antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
KDM2B synonym: CXXC2; FBXL10; Fbl10; JHDM1B; PCCX2; lysine-specific demethylase 2B; CXXC-type zinc finger protein 2; F-box and leucine-rich repeat protein 10; F-box protein FBL10; F-box/LRR-repeat protein 10; JEMMA (Jumonji domain, EMSY-interactor, methyltransferase motif) protein; [Histone-H3]-lysine-36 demethylase 1B; jmjC domain-containing histone demethylation protein 1B; jumonji C domain-containing histone demethylase 1B; lysine (K)-specific demethylase 2B; protein-containing CXXC domain 2

EMD Millipore
rabbit polyclonal
  • western blot; mouse; 1:2000; fig 6
EMD Millipore KDM2B antibody (Merck Millipore, 09-864) was used in western blot on mouse samples at 1:2000 (fig 6). Genome Biol (2016) ncbi
rabbit polyclonal
  • western blot; human; fig 1
EMD Millipore KDM2B antibody (Millipore, 09-864) was used in western blot on human samples (fig 1). Oncogene (2016) ncbi
rabbit polyclonal
  • western blot; human; fig s3
EMD Millipore KDM2B antibody (Merck Millipore, 17-10264) was used in western blot on human samples (fig s3). Oncotarget (2015) ncbi
rabbit polyclonal
  • western blot; human
EMD Millipore KDM2B antibody (Millipore, 09-864) was used in western blot on human samples . PLoS ONE (2014) ncbi
Articles Reviewed
  1. Pandolfini L, Luzi E, Bressan D, Ucciferri N, Bertacchi M, Brandi R, et al. RISC-mediated control of selected chromatin regulators stabilizes ground state pluripotency of mouse embryonic stem cells. Genome Biol. 2016;17:94 pubmed publisher
  2. Han X, Zha Z, Yuan H, Feng X, Xia Y, Lei Q, et al. KDM2B/FBXL10 targets c-Fos for ubiquitylation and degradation in response to mitogenic stimulation. Oncogene. 2016;35:4179-90 pubmed publisher
  3. Lu S, Yang Y, Du Y, Cao L, Li M, Shen C, et al. The transcription factor c-Fos coordinates with histone lysine-specific demethylase 2A to activate the expression of cyclooxygenase-2. Oncotarget. 2015;6:34704-17 pubmed publisher
  4. Karoopongse E, Yeung C, Byon J, Ramakrishnan A, Holman Z, Jiang P, et al. The KDM2B- let-7b -EZH2 axis in myelodysplastic syndromes as a target for combined epigenetic therapy. PLoS ONE. 2014;9:e107817 pubmed publisher